Drug Administration 2011

download Drug Administration 2011

of 98

Transcript of Drug Administration 2011

  • 7/30/2019 Drug Administration 2011

    1/98

    DRUG ADMINISTRATION

    1

    dr. Prajogo Wibowo, M. Kes

  • 7/30/2019 Drug Administration 2011

    2/98

    2

    THE PREPARATION CAN BE

    DISTINGUISHED INTO

    INTERNAL PREPARATION

    ORAL

    STOMACH

    INTESTINAL

    DRUGS LABEL : WHITE

    EXTERNAL PREPARATION

    ALL OF MEDICATION

    but

    ORAL INTESTINAL

    DRUGS LABEL : BLUE

  • 7/30/2019 Drug Administration 2011

    3/98

    SYSTEMIC & NON SYSTEMIC MEDICATIONS

    3

    1. INTERNAL PREPARATION

    SYSTEMIC : ANTIBIOTIC (SYSTEMIC)

    ANTIHYPERTENSION, ANALGESIC

    NON SYSTEMIC : ANTIHELMINTIC

    LOCAL ANAESTHETIC, ANTIMICROBIAL(INTESTINAL), LOCAL ANTACID

    2. EXTERNAL PREPARATION

    SYSTEMIC : PARENTERAL INJECTION

    INHALER, SUPPOSITORIA

    NON SYSTEMIC : VAGINAL TABLET,

    TOPICAL STEROID, GARGLE,SUPP

  • 7/30/2019 Drug Administration 2011

    4/98

    MANAGEMENT OF MEDICATION

    1. INTERVAL OF MEDICATION

    2. TIMING OF MEDICATION

    3. TECHNIQUE OF MEDICATION

    4

  • 7/30/2019 Drug Administration 2011

    5/98

    5

    1. INTERVAL OF MEDICATION

    examples :* HOURLY

    * EVERY (THREE-HOURS)* THREE TIMES A DAY

    2. TIME OF MEDICATION

    examples :* in the morning, in the midday, in the night

    * before, after, or during meals; before sleeping

    * during episode, during attack, after attack

    3. TECHNIQUES OF MEDICATION

    * ROUTE OF ADMINISTRATION : TOPICAL AND NON-TOPICAL DRUGS

    * DRUG DOSAGE FORMS

  • 7/30/2019 Drug Administration 2011

    6/98

    INTERVAL OF MEDICATION

    Determined by :

    * HALF-LIFE TIME (t 1/2) OF DRUGS :

    Ultrafast, Fast, slow, very slow

    Example :

    Reserpin has t 1/2 15 minutes and 36 hours of duration

    DURATION OF DRUG ACTION / EMERGENCY SETTING

    In emergency condition, in particular clinical treatment

    6

  • 7/30/2019 Drug Administration 2011

    7/98

    HALF-LIFE TIME (T 1/2)

    ULTRAFAST :amoxicillin, cloxacillin, flurosemide, penicillin-G

    FAST :

    paracetamol, ampicillin, hydrocortison

    SLOW :

    doxicillin, griseofulvine, proctolol

    VERY SLOW :

    barbiturate, diazepam, digitoxin, phenylbutazon

    7

  • 7/30/2019 Drug Administration 2011

    8/98

    STANDARD ADMINISTRATION TIMES

    DAILY

    Once : 10.00 (morning)/22.00 (night)

    Twice : 10.00 , 14.00

    Three times : 10.00 , 14.00, 18.00

    Four times : 10.00, 14.00, 18.00, 22.00

    EVERY12-hourly : 10.00, 22.00

    8-hourly : 06.00, 14.00, 22.00

    6-hourly : 06.00, 12.00, 18.00, 24.004-hourly : 06.00, 10.00, 14.00, 18.00. 22.00, 02.00

    8

  • 7/30/2019 Drug Administration 2011

    9/98

    TIMING OF MEDICATION

    BASED ON :

    * CHEMICAL PROPERTIES OF DRUGS* PHYSIOLOGICAL PROPERTIES OF GASTROINTESTINAL

    TRACT

    POSSIBLE INTERACTIONS :

    1. DRUG AGAINST DRUG2. DRUG AGAINST GASTROINTESTINAL CHYME

    3. DRUG AGAINST GASTROINTESTINAL PHYSIOLOGY

    THE CONSEQUENCES :1. DRUG : reaction occurs --> impaired absorption; break-

    down of drug

    2. GASTROINTESTINAL TRACT : drug irritation, impairedmotility, delayed gastric emptying, reduced absorption.

    9

  • 7/30/2019 Drug Administration 2011

    10/98

    OVERCOME

    1. DETERMINATION OF APPROPRIATE TIMING

    IN DRUG ADMINISTRATION

    2. MANAGING THE PRIORITY ORDER OF

    DRUGS.

    3. CHOOSING THE APPROPRIATE DRUG

    TYPES

    10

  • 7/30/2019 Drug Administration 2011

    11/98

    TIMING OF MEDICATION

    IN THE MORNING :

    * Steroid * Laxative Bisacodyl tablet

    * Diureticum * Suppositoria

    * Antihypertension * Vaginal tablets

    * Hypnotics

    * Cimetidine

    * Anticholesterolemia

    IN THE NIGHT :

    * Contraceptive pills

    DURING DAILY ACTIVITIES

    DURING MEALWith meal : - promptly after meal

    - During Meal

    Empty Stomach : 1 hour before meal

    2 hours after meal

    11

    DURING EPISODE

    * Pectoral angine drugs

    * Drugs for migraine-cephalgy

    * Antiasthmatic drugs

  • 7/30/2019 Drug Administration 2011

    12/98

    DRUGS & PHYSIOLOGY OF GIT

    Factors affecting drug

    1. Chemical properties

    2. Gastric pH3. GI tract motility

    12

  • 7/30/2019 Drug Administration 2011

    13/98

    13

    ANTICHOLINERGIC DRUGS reduce :

    * Secretion* Intestinal peristaltic

    These drugs should be taken one hour before meal

    BELLADONA ALKALOID GROUP : Tinct.BelladonaAtropin extr. Belladona Hormotropin

    Scopolamin Oxypheninium

    Methylscopolamine Mepenzolate

    Butylscopolamine Bevonium

    QUATERNARY COMPOUNDS Clidinium

    Propanteline

  • 7/30/2019 Drug Administration 2011

    14/98

    DRUGS AND FOODS

    1. Drugs interferred by gastric chyme

    ANTIMICROBES :

    Ampicillin

    AmoxicillinErythromycin

    Lincomycin

    Oxytetracycline

    Penicilline G/VTetracycline

    All these drugs should better be taken during "emptystomach"

    14

    Isoniazide

    Rifampicin

    OTHERS :

    Levodopa

    Penicillinamine

    PropantelineParacetamol

  • 7/30/2019 Drug Administration 2011

    15/98

    2. DRUGS THAT SYNCHRONIZED

    WITH CHYME (FOOD)ANTIMICROBES :

    Doxycycline

    Doxycycline hyclateErthromycin ethylsuccinate

    Griseofulvin

    Nitrofurantoin

    The above mentioned drugs should be taken "with meals"

    15

    OTHERS :

    Hydralazine

    HydrochlortiazidePropanolol

    Metroprolol

    Reserpine

  • 7/30/2019 Drug Administration 2011

    16/98

    3. STOMACH-IRRITATING DRUGS

    Aminophylline

    Acetyl salicilic acid

    Codein

    PhenylbutazonFerrosulphate

    Hydrocortison

    Indomethacine

    Isoniazide

    1. The possibility not to be taken by patients with gastritis

    2. Some are administered in contained stomach or excessive water drinking

    3. Some are in favour given with milk 16

    Chlorpromazine

    Metronidazole

    Nitrofurantoin

    PrednisoneReserpine

    Mephenamic acid

    Pirazolone

  • 7/30/2019 Drug Administration 2011

    17/98

    INTERACTIONS BETWEEN DRUGS

    DRUGS THAT INTERACT WITH ANTACIDS IN STOMACH :ANTBIOTICS :

    Amoxicillin

    Ampicillin

    Cloxacillin

    Nitrofurantoin

    OxytetracyclinePenicillin V

    Sulphonamide

    Tetracycline

    EXAMPLE OF MEDICATION TIMING OF THE INTERACTIVE DRUGSR/ Ampicillin 500 mg cap No. XV

    S 3. dd.cap.I (1) hac 1 hour before mealR/ Antacid tab No.XX

    S3.dd.tab.I (1) hpc 1 hour after meal 17

    OTHERS :

    Acetylsalicilic acid

    Digitalis

    Dicumarol

    Phenotiazine

    Ferrous preparation

    Isoniazid

    Chlordiazepoxide

    Levodopa

    IndomethacinePropanolol

  • 7/30/2019 Drug Administration 2011

    18/98

    MEDICATION TECHNIQUE

    DRUG DOSAGE FORMS

    ROUTE OF ADMINISTRATIONSPECIFIC- DRUG MEDICATION

    PARENTERAL DRUG MEDICATION

    18

  • 7/30/2019 Drug Administration 2011

    19/98

    METHOD OF MEDICATION

    TERMS : SITES :

    * Oral Mouth

    * Peroral (per os) GI tract system via mouth

    * Sublingual Under the tongue* Parenteral Other sites than GI tract (by injection)

    * Intravenous into vena

    * Intraarterial into artery

    * Intracardiac into the heart

    * Intraspinal/intrathecal into spine* Intraosseous into bone

    * Intraarticular into joint

    19

  • 7/30/2019 Drug Administration 2011

    20/98

    20

    Intrasynovial Synovial fluid cavity

    Intracoutaneous or intradermal into skin

    Subcutaneous under skin

    Intramuscular into muscle

    Epicutaneous (Topical) Skin surface

    Transdermal Skin surface

    Conjunctival Conjunctiva

    Intraoccular Eye globe

    Intranasal Nose

    Aural Ear

    Intrarespiratory Lung

  • 7/30/2019 Drug Administration 2011

    21/98

    THE USAGE OF DOSAGE FORMS

    Sublingual tablet

    trochition and lozenges

    Parenteral solution, suspension

    Epicutaneous/Transdermal intment, cream, paste, powder,

    aerosol, lotion, and transdermal, disc, and solutionattachment

    21

  • 7/30/2019 Drug Administration 2011

    22/98

    THE USAGE OF DOSAGE FORMS

    Conjunctival ointment

    Intraoccular/intraaural solution, suspension

    Intranasal solution, spray, inhalant, ointment

    Intrarespiratory aerosolRectal solution, ointment, suppositoria

    Vaginal solution, ointment, emulsified

    foam, tablet, insert, suppositoria,

    sponge

    Urethral solution, suppositoria

    22

  • 7/30/2019 Drug Administration 2011

    23/98

    DRUGS THAT ARE USED SPECIFICALLY

    1. SUBLINGUAL TABLET

    For cardiac diseases : angina / asthma(nitroglycerin,

    isoprenalin)

    2. CHEWING TABLET

    Drugs for gastritis

    3. LOZENGESMouth freshener (anti inflammation)

    23

  • 7/30/2019 Drug Administration 2011

    24/98

    MULTI-LAYER TABLET

    Tablets that are destroyed in intestine

    Tablet :

    * Unchewed but powdered

    * Without milk, alkaline drinks, or antacid

    DRUGS THAT NEED EXCESSIVE DRINK (200-300 ml)

    * Sulfa group

    * Metronidazol

    * Erythromycin

    * Amoxicillin

    * Aspirin

    24

  • 7/30/2019 Drug Administration 2011

    25/98

    DRUGS THAT ARE WITHOUT

    EXCESSIVE DRINK

    Antigastritis drug/antacid suspension

    DRUGS THAT ARE TAKEN WITHOUT MILK Vitamin C+ Ferrous

    Antienteretis

    Enteric coated tablet Tetracycline

    PEDIATRIC DRUG ADMINISTRATION

    Tablet powder/pulveres dissolved into : Honey

    Sugar water

    Jelly

    Corn oil

    25

  • 7/30/2019 Drug Administration 2011

    26/98

    THE APPLICATION OF OPTHALMIC OINTMENT / EYE DROP

    1. The hand holds the ointment after washed first to be clean

    2. Open the tube's cap then discard the first 1/4 inch length of the

    ointment, because this portion is often dry.

    3. With one finger, press downward the lower lid meanwhile the

    patient is staring upward

    4. Press and rub the eye ointment as long as 1/4 - 1/2 inch onto

    the inner side of the lid without touching it nor eye globe.

    5. Close the eye and rotate the eye globe in all direction (possibly

    the vision will become slightly blurred ).

    6. Cap the tube immediately without touching the tips of cap nor

    tube. 26

  • 7/30/2019 Drug Administration 2011

    27/98

    1. Cough out the sputum as much as possible.

    Aerosol is shaked before use2. Place it as the recommendation of the

    manufacterer. It is usually set upside down.

    3. Place the oral edge of tube inside the mouth,face upward by moving head posteriorly.

    4. Breath out slowly, empty the lung volume asmuch as possible.

    5. Press the tube content in order to spraymeanwhile immediately inhalate it deeply withtounge position remains still below.

    6. Hold the breath within 10 - 15 seconds.

    7. Then, expire the air through nares. 27

  • 7/30/2019 Drug Administration 2011

    28/98

    28

  • 7/30/2019 Drug Administration 2011

    29/98

    INHALANT MEDICATION

    1. Cough out the sputum as much as possible.

    2. Place the capsule into the inhaler container as the

    manufacturer's recommendation

    3. Breath out slowly, empty the lung volume as much as

    possible.

    4. Place the oral tip of tube inside the mouth.

    5. Face upward by moving head posteriorly.

    6. Breth in deeply through inhaler

    7. Hold the breath for 10 -15 seconds

    8. Exhale the breath through nares.

    29

  • 7/30/2019 Drug Administration 2011

    30/98

    30

  • 7/30/2019 Drug Administration 2011

    31/98

    NASAL DROP

    1. Sit with your head facing upward, or pad your

    shoulder with a pillow under.

    2. Insert the tip of dropper asdeep as 1cm into the

    nares.

    3. Drip some drops of the drugs as recommended.

    4. Nod downward your head so that the head is over

    the knee.

    5. Sit up repetitively for several times so that the

    drop can enter the pharynx.

    31

  • 7/30/2019 Drug Administration 2011

    32/98

    32

  • 7/30/2019 Drug Administration 2011

    33/98

    NASAL SPRAY

    Nod down the head slightly.

    The other nose is closed by pressing the nares with

    your finger.

    The sprayer is inserted into the opened nares by

    pressing the vial, so that its content will be out andinhalte gently, then do the same as the

    abovementioned.

    33

  • 7/30/2019 Drug Administration 2011

    34/98

    34

  • 7/30/2019 Drug Administration 2011

    35/98

    EAR DROP

    The best is the head in slanting position

    Gently the upper part of the ear lobe is slightlyattracted upward (in adult) and the middle one in

    children in order to let the opening is seen clearly.

    Drip some ear drops and wait for approximately 5minutes before doing the same into another one.

    In some products, it is recommended to close theear opening with cotton ball.

    35

  • 7/30/2019 Drug Administration 2011

    36/98

    36

  • 7/30/2019 Drug Administration 2011

    37/98

    SUPPOSITORIA

    Suppositoria is prepared to be out of the container. When itis too flaccid, it would better be cooled first, whereas if it istoo hard, heat it by placing it inside your fist.

    Lay down with slanting position and one of the lowerextremities is abducted to the abdomen.

    Insert gently the suppositoria into the anal openingmeanwhile it is rotated foreward with one of your hands.Keep lying for several minutes.

    37

  • 7/30/2019 Drug Administration 2011

    38/98

    38

  • 7/30/2019 Drug Administration 2011

    39/98

    INTRAVAGINAL MEDICATION

    In general, intravaginal medication is limited to thelocalized application for which ointments ortablets are available to insert into vagina andusually by the time of going to bed, such as

    metronidazole and primaricin for vaginitis causedby trichomonas and candida.

    The drugs may be used in the form of swabbingliquid, others in the forms of spermaticide (to killspermatocyte), foam tablet,and cream.

    39

  • 7/30/2019 Drug Administration 2011

    40/98

    40

  • 7/30/2019 Drug Administration 2011

    41/98

    SKIN DRUGS

    THE TOPICAL DRUGS USED FOR SKIN IN GENERAL

    INCLUDE :

    1. WATTER (SOLUTION)

    2. ALCOHOL (TINCTURE)

    3. POWDER

    4. WET POWDER (SHAKED POWDER)

    5. CREAM

    6. PASTE

    7. OINTMENT

    41

  • 7/30/2019 Drug Administration 2011

    42/98

    LOCATION

    Back and chest

    Genitalia

    Scalp

    Hand and arm

    Skin fold

    Lower extremities

    Face

    42

    All types Powder, watered powder,

    cream solution.

    Powder, watered powder,

    cream solution. Water (solution), alcohol,

    cream.

    Powder, water solution,alcohol, ointment, wet powder,paste, cream.

    Watered powder (solution),alcohol, ointment, wet powder,cream.

    All types except for eye skin.

  • 7/30/2019 Drug Administration 2011

    43/98

    THE CHOOSING OF DRUGS IS ON THE

    BASIS OF THE SKIN DISORDERS,

    THUS THE WET CONDITION OF THE

    SKIN DISORDERS NEEDSAPPLICATION OF WET PREPARATION,

    WHILE THE DRY SKIN USES

    SEMISOLID PREPARATION.

    43

  • 7/30/2019 Drug Administration 2011

    44/98

    Vesicles, edema, erythrema Crust, itching infection Water (solution) - wet compression Powder, lotion, sprays Cream (o/w) Cream (w/o) and and ointment

    44

    Desquamation, erythrematous, itching,

    drying

  • 7/30/2019 Drug Administration 2011

    45/98

    THE ADVANTAGES OF PARENTERAL MEDICATION :

    1. The drug action can be reached rapidly, strong, and

    complete

    2. No irritation or not destroyed by gastric acid

    3. Can be administered to the patients with unconsciousness

    or swallowing unability

    45

    Parenteral medication can be undertaken :

    1. By injection with syringe

    2. Through infusion liquid (more than 10 ml volume)

  • 7/30/2019 Drug Administration 2011

    46/98

    ADVANTAGES

    1. In general, it is expensive and impractical

    2. Easy to contaminate

    3. Able to damage blood vessel, tissue, and nerve

    4. The administration methods should be adjusted,

    because of being slow and rapid

    46

  • 7/30/2019 Drug Administration 2011

    47/98

    CONCLUSIVELY, PARENTERAL MEDICATION ARE

    BASED ON 2 MAIN CONSIDERATIONS :

    1. Expectation of rapid drug action

    2. the required drugs are in the form of parenteral

    dosage forms

    47

  • 7/30/2019 Drug Administration 2011

    48/98

    INTRAVENOUS ADMINISTRATION NEEDS THE

  • 7/30/2019 Drug Administration 2011

    49/98

    SKILLFULNESS, GREAT ATTENTION, AND

    PRECATIOUSLY WITH ANTISEPTIC TECHNIQUES AND

    ALSO NEED CLOSE MONITORING OF DRUG ACTION.

    Physicians judge the decision of intravenous medication basedon as follows :

    1. whenever other routes of administration are considereimpossible whereas the terapy management must beimplemented promptly. For example :

    * Methicillin in stomach will be broken down by acid,whereas via intramuscular method is impossible because oflarge volume required, then the chosen appropriate

    method is intraveous route.

    * The multiple drug medication in large volume is impossible

    to give intramuscularly regarding to giving risepainfulness; similarly, subcutaneous method will result inwider inflammation.

    * In very irritative drug by intramuscular and subcutaneousmethod, it can be diluted into infussion.

    49

  • 7/30/2019 Drug Administration 2011

    50/98

    50

    In the specific clinical settings, the rapid administration isrequired for patients with serious condition.

    In patients with high tendency to be hemorrhagic(thrombocytopenia or hemophilia and anticoagulantadministration), intramuscular and subcutaneousmedication will cause formation of hematoma which ispainful and extensive or bleeding.

    For supplementary nutrition, in patients with GIdisturbances, peroral intake is not adequate, and sodoes patient with gastrointestinal post-operative condition.

    * Patients with vomiting and nausea at certain level,

    such as severe hyperemesis gravidarum,unconsciousness, or swallowing unability.

    Beside intravenous drugs and liquid administration, itis also important to give blood or bloodcomp[onen in

    certain cases.

    INTRODUCTION TO INJECTION DRUGS

  • 7/30/2019 Drug Administration 2011

    51/98

    INTRODUCTION TO INJECTION DRUGS

    Injection drug is a sterilized preparation in the forms of :

    1. Liquid, consisting of :

    Solution, the active ingredient disolves in it and theavailable packaging is in ampule or vial.

    Suspension, unsoluble active ingredient, issuspended thoroughly in the suspension using

    suspension agent.Emulsion, the liquid containing the mixture of waterand oil.

    2. Dry Powder, including :

    Soluble Ingredient, mixed with solvent before use,this ingredient is not long-standing that breaks downin the solution.

    Insoluble Ingredient, mixed with liquid when it will beused, because it is not long-standing in solution, but

    broken down. 51

  • 7/30/2019 Drug Administration 2011

    52/98

    DELAYING THE DRUG ABSORPTION INTO THE BLOOD

    VESSELS, IN THE REASON TO LENGTHEN THE DRUG

    ACTION, SUSPENSION OR SOLUTION IN BEAN OIL OR

    SESAME OIL IS FREQUENTLY USED, FOR EXAMPLES,PENICILLIN AND SEXUAL HORMONE SUSPENSION,

    GIVEN INTRAMUSCULARLY.

    52

  • 7/30/2019 Drug Administration 2011

    53/98

    THE CONTAINER OF INJECTION DRUGS

    1. AMPULES

    It is made from glass or plastics with various sizes,from 1 ml (adrenalin) up to 10 ml (aminophyline)

    generally for once usage.

    53

  • 7/30/2019 Drug Administration 2011

    54/98

    54

  • 7/30/2019 Drug Administration 2011

    55/98

    THE PREPARATION TO USE :

    With clean hands, align the fine wound line on the

    ampule neck, then using alcohol cotton clean it and

    break it ; if the ampule head is made from plastics,

    rotate the ampule head untill it is separated completely.

    55

    2 VIAL

  • 7/30/2019 Drug Administration 2011

    56/98

    2. VIAL

    It is made from glass with rubber cap fixed with filmmetal surrounding the bottle lip, generally can be usedrepetitively.

    The filling of drug solution into syringe is as follows :

    Solution :

    Suck the air as much as needed

    Make the vial rubber clean using sterilized alcoholcotton

    Prick the syringe into the vial while the upside-down position of the vial .

    Press the air into the vial then directly pump-in thesolution as much as needed, the needle shouldbe always in the solution border.

    Make the syringe free from air and clean it, washthe hands.

    56

  • 7/30/2019 Drug Administration 2011

    57/98

    57

  • 7/30/2019 Drug Administration 2011

    58/98

    HYPODERMIC EQUIPMENTS

    SYRINGE is an equipment to get water or solution into the

    body or body cavities.

    HYPODERMIC SYRINGE is syringe to use for subcutanous,

    intramuscular, and intravenous methods. It is a sucking typeand characterized by the main components including a metal

    piston and a tube made from glass with various sizes.

    1. Tuberculin syringe : small size with capacity no more than

    1 ml .

    0.1 - 0.001 ml.

    Hypodermic Syringe : Larger size with capacity 2 - 50 ml.

    58

  • 7/30/2019 Drug Administration 2011

    59/98

    59

  • 7/30/2019 Drug Administration 2011

    60/98

    DISPOSABLE SYRINGE :

    Made from plastics with larger size thanTuberculin syringe (5 ml) for once use only,packed with steril state and separated

    needle.

    In general, it is used the administration ofantibiotics,antihistamine,heparin, tranquilizer,vitamin, etc.

    60

  • 7/30/2019 Drug Administration 2011

    61/98

    61

  • 7/30/2019 Drug Administration 2011

    62/98

    HYPODERMIC NEEDLES

    This needle typically is made from stainless steel,

    hyperchromed steel, carbon steel, chromium, platinum,

    silver or gold.

    The form of hypodermic needles based on :

    1. Length

    2. Thickness needle

    3. Sectioning: sharp-angle sectioned needle

    62

  • 7/30/2019 Drug Administration 2011

    63/98

    63

  • 7/30/2019 Drug Administration 2011

    64/98

    LONG, SHARP-ANGLED OR LONG THICK NEEDLES ARE

    USED FOR INJECTION, LOCAL ANESTHESIA, SUCKING,

    HYPODERMOLYSIS AND SUBCUTANEOUS INJECTION.

    Figure:

    Short-sectioned needle

    Long-sectioned needle

    64

    Short, sharp- angled needles are used for

    injections : intravenous, infusion, and transfusion,whereas the special short, sharp-angled needles

    are used for intradermal and spinal injections.

    NEEDLE SIZE

  • 7/30/2019 Drug Administration 2011

    65/98

    NEEDLE SIZE

    The choosing of needle size on the basis of

    1. Safety2. Flow volume

    3. Patient's convenience

    4. Penetration depth

    The unit of needle size is GAUGE referring to the outerdiameter of canula or needle shaft.

    In general the size is 1 - 27 gauge, with the length not lessthan 1/4 inch and more than 3.5 inches.

    For several biopsies and spinal tranfusion, the needles are

    16 - 19 gauge in size and 0.5 - 3.5 inches in length For local anesthesia, the needles are from 26 gauge with

    1/2 inch to 20 gauge with ? inches.

    For intravenous transfusion, the needles are from 19 gaugewith 1.25 inches to 15 gauge with 2.5 inches.

    65

  • 7/30/2019 Drug Administration 2011

    66/98

    66

  • 7/30/2019 Drug Administration 2011

    67/98

    THERE ARE ALSO MANY OTHER

    UTILITIES :

    1. Caudal needle

    2. Epidural needle

    3. Intravenously anesthetic needle4. Blood transfusion needle

    5. Spinal needle

    6. Biopsy needle7. Cerebral angiographic needle

    67

    O S O S O

  • 7/30/2019 Drug Administration 2011

    68/98

    ROUTES OF ADMINISTRATION IN

    INJECTION DRUGS

    1. INTRADERMAL OR INTRACUTANEOUS

    Dosage form : Solution and Suspension

    Volume : 100- 200 I.U per I.C

    Purpose : Tuberculine Test and Immunization

    Equipments : Disposable syringe with small, short

    size needle, Desinfected cottons

    68

  • 7/30/2019 Drug Administration 2011

    69/98

    69

  • 7/30/2019 Drug Administration 2011

    70/98

    ROUTES OF ADMINISTRATION IN

    INJECTION DRUGS

    2. SUBCUTANEOUS OR HYPODERMAL INJECTION

    Dosage form : Solution or oil

    Volume : No more than 2 ml

    The injection under skin should be conducted with non-irritantdrugs which are soluble either in water or oil, but the effect is not

    as rapid as IM or IV method. It is easy to do by patients

    themselves, such as insulin administration.

    3. In BCG administration for infants, injection viadermal and subcutaneous methods may developlymphadenitis.

    70

  • 7/30/2019 Drug Administration 2011

    71/98

    71

  • 7/30/2019 Drug Administration 2011

    72/98

    THIS METHOD IS ALSO USED IN THE

    ADMINISTRATION OF HEPARIN ANDEPINEPHRINE SUSPENSIONS.

    Skin has poor blood vasculature, thereby the drugs that

    will be absorbed by blood vessels and the nonsoluble

    drugs diffuse into lymphatic vessels.

    72

  • 7/30/2019 Drug Administration 2011

    73/98

    73

    INJECTION TECHNIQUES1 W h th h d th hl

  • 7/30/2019 Drug Administration 2011

    74/98

    1. Wash the hands thoroughly

    2. Localize the injection site on the lateral surface of upper arm,anterior surface of thigh or abdominal region.

    3. Clean the skin area with desinfectant4. Pinch the skin as thick as the skin itself

    5. Prick the needle into the skin on the base of skinfold with theangle of 20 - 30 degrees

    6. The pinch is then released7. Re-suck the syringe to ascertain that it did not prick the blood

    vessel (if there is blood in it, repeat the procedure)

    8. Inject the drug slowly and gradually within 0.5 - 2 minutes; if

    too quick, possibly edema or collapse of blood vesseldevelops

    9. The needle is immediately removed, cover the injection sitewith adhesive plaster.

    10. Observe the patient condition; attention should be given that

    the repeated injection may appear overdosis. 74

  • 7/30/2019 Drug Administration 2011

    75/98

    3. INTRAMUSCULAR INJECTION

    Dosage form : Solution, suspension in water oroil

    Volume : No more than 4 ml

    In injection into muscles, the soluble drug resorptionwill last within 10 - 30 minutes.

    The adventages :

    Easy, safer, good tolerated, rapid resorption, andrarely develops necrosis. For very irritative drugs, this

    intramuscular method is preferred than subcutanousmethod.

    75

  • 7/30/2019 Drug Administration 2011

    76/98

    76

  • 7/30/2019 Drug Administration 2011

    77/98

    INJECTION PROCEDURE

    Localize the muscle to choose:

    Ventro Gluteal : thicker, no main nerve fibers and blood

    vessels. Choose the upper lateral quadrant, in Medial

    Gluteal, take attention on ischiadic nerves and SuperiorGluteal Artery.And patient position should be facing laterally,

    facing downward, or standing.

    It is not performed to infants and young children.

    77

  • 7/30/2019 Drug Administration 2011

    78/98

    VASTUS LATERALIS

    Middle aspect of thigh : very poor nerve fibers and bloodvasculature.

    Position : supine, or sitting

    Volume : 2.5 - 3 ml

    Deltoid muscle : Easy, with position of facing laterally, sitting, or standing,

    needs attention that the area is very limited and the existance of largebone, bood vessels, and nerve fibers.

    Drug volume :1. no more than 2 ml.2. Wash hands thoroughly3. Make the patient ensure and explain the procedure

    4. Rub desinfectant on the skin5. Ask the patient to let the muscles relaxed, because if the muscle is incontraction will the drug liquid flow into the surrounding tissue leading toirritation and pain sensation.

    78

  • 7/30/2019 Drug Administration 2011

    79/98

    Drug volume :

    6. Shoot the needle in perpendicular position (90 degrees)to the skin surface

    7. Re-suck to ensure if it shot blood vessel (if it did so,repeat the procedure from point 4, or replace with newsyringe, if any)

    8. Inject the drug by pressing the pump slowly and

    gradually to diminish pain sensation9. Remove the needle quickly

    10. The injection site is press using the other hand withsterilized cotton, fix it with plaster

    11. Observe the patient's reaction, necessarily keep the

    patient calm12. Clean the hands and used equipments

    79

  • 7/30/2019 Drug Administration 2011

    80/98

    4. INTRAVENOUS DRUG ADMINISTRATION

    Materials :

    Syringe filled with air-free drug liquid,

    Needle of 20 gauge, long and moderate thickness

    Desinfectant

    Cotton, plasters, and tourniquette

    Injection Procedure :

    1. Wash the hands thiroughly

    2. Ensure the patient and explain what will be done

    3. Localize the injection site, choose forearm slightly lower from cubital

    fossa. The vein lies more superficially and is not covered and easy toligate.

    4. The patient is asked to be relaxed with fisting the related hand.

    5. Tourniquette is set up, then see the vein to be swollen while giving

    desinfectant on to the skin area.

    80

  • 7/30/2019 Drug Administration 2011

    81/98

    81

    4 INTRAVENOUS DRUG ADMINISTRATION

  • 7/30/2019 Drug Administration 2011

    82/98

    Injection Procedure :

    6. Vein is stabilized by replacing the pressing hand to the skin inline with the vein longitudinal axis, using the other hand.

    7. Direct cardially the needle to vein with 35 degree of angle,

    shoot the needle slowly into 3-5 mm depth of vein

    8. Do aspiration, if there is blood inside the syringe, it means that

    the needle has aimed to the vein, instead, try again.9. Tourniqette then is removed

    10. Inject the drug slowly, observe the pain sensation, swelling or

    hematoma; if the needle is still in vein, try to suck again.

    11. The needle then should be removed immediately while the

    injection site is press with cotton and subsequently cover itwith plaster.

    12. Observe the patient's reaction, meanwhile wash your hands

    and clean the used equipments

    82

    4. INTRAVENOUS DRUG ADMINISTRATION

  • 7/30/2019 Drug Administration 2011

    83/98

    INTRAVENOUS ADMINISTRATION OF FLUID

    Intravenous fluids refers to fluid that is administered

    intravenously in large amount through infusion.

    It is estimated that about 40% of the drugadministration at hospitals were conducted by

    injection and it is likely increasing recently.

    83

  • 7/30/2019 Drug Administration 2011

    84/98

    THE CONTAINER OF INFUSION FLUID

    1. It is made from glass, consisting of 2 types based onthe difference in air ventilation :

    a. Air ventilation is outside of the bottle, at the tip of

    infusion set through filter at a bottle spike.

    b. Air ventilation through the tube in the bottle, the tubeopening is able to be passed through.

    84

  • 7/30/2019 Drug Administration 2011

    85/98

    85

  • 7/30/2019 Drug Administration 2011

    86/98

    86

  • 7/30/2019 Drug Administration 2011

    87/98

    87

  • 7/30/2019 Drug Administration 2011

    88/98

    2. THE CONTAINER IS MADE FROM FELXIBLE

    PLASTICS POLYVINYL CHLORIDE OR SEMIRIGID

    POLYOLIVIN. The supporting equipments for infusion administration are

    infusion set that is to move the fluid into blood vein. It should

    meet the requisites of being sterilized, free-pirogen, and

    disposable

    Though it is produced by a variety of manufacturers, themain components and parts are the same, including :

    1. Spike as the breaker against rubber seal in the spike

    hole.

    2. Drip chamber

    88

    THE PURPOSE OF INTRAVENOUS FLUID

  • 7/30/2019 Drug Administration 2011

    89/98

    THE PURPOSE OF INTRAVENOUS FLUID

    ADMINSTRATION IN SOME CLINICAL SETTINGS

    IS : To correct the imbalanced body fluid (as replacement) To correct the imbalanced body electrolytes

    To provide basic nutritional elements

    Voluminous parenteral hyperalimentation that overwhelming

    the normal nutrition

    As the carrier of other drug adminstration

    89

    NAME CONCENTRATION PURPOSE

  • 7/30/2019 Drug Administration 2011

    90/98

    1. AminoAcids (synthetic)

    Aminosyn

    Veinamine

    2. Dextrose (Glucose,D5/W)3. Dextrose&NaCl

    4. Lactate's Ringer

    (Harmann)

    NaCl

    KCl

    CaCl2Na Lactate

    5. Protein (hydrolized)

    Aminosol

    CPH-5

    6. Ringer's

    NaClKCl

    CaCl2

    7. Natrium Lactate

    90

    5.5-&%

    8%

    2.5 - 50%

    5-20%

    NaCl 0.11 - 1.9%

    0.60%

    0.03%

    0.02%0.30

    5% casein&fibrin

    0.86%

    0.03%

    0.033%

    1/6M

    Fluid &nutrition

    Fluid & Nutrition

    Nutrition & Electrolytes

    Systemic alkalizer &

    nutrient supplement

    Fluid & nutrient

    supplement

    Fluid & nutrient

    supplement

  • 7/30/2019 Drug Administration 2011

    91/98

    THE INTERMITTEN ADMINISTRATION OF ANTIBIOTICS

    AND OTHERS

    Such medication may be performed by one of the three following methods :

    A. Directly Intravenous Injection : volume of 1 - 5 ml within 1 - 5 minutes.

    Orinject the injector of the hanging infusion bottle into the injection site.

    This method is appropriate for limited amount of drug and the drug

    which endanger if given in multiple method.

    B. Volume Control Method : it refers to the infusion adminstration with

    accurate dosage in expected flow through volume control set consisting

    of a calibrated plastic chamber below the main infusion bottle which is

    frequently along with free liquid administration.

    91

  • 7/30/2019 Drug Administration 2011

    92/98

    92

    THE PROCEDURE OF INTERMITTENT

  • 7/30/2019 Drug Administration 2011

    93/98

    THE PROCEDURE OF INTERMITTENT

    ADMINISTRATION OF INTRAVENOUS LIQUID WITH

    VOLUME CONTROL SET

    1. Using aseptic technique, the spike of VC set is inserted intothe main infusion bottle or separated bottle.

    2. The tube line is emptied from air by opening the upper

    clamp so that the liquid flows.3. Open the clamp over the calibrated chamber to let 25 -

    50 ml of liquid enter into it from the bottle.

    4. Close the upper clamp.

    5. Inject the drug through the connecting hole in therubber

    cap of the VC set.6. Re-open the upper clamp to let the flow up to 50 - 150

    ml, then close it.

    7. Open the lower clamp to make liquid flows

    93

  • 7/30/2019 Drug Administration 2011

    94/98

    94

  • 7/30/2019 Drug Administration 2011

    95/98

    The administration of this infusion drip is related to thesecond liquid. Through venipuncture, the drug flow will beregulated in one intravenous system.

    This administration give rise the following advantages :

    1. PB technique can avoid unnecessarily othervenipuncture.

    2. The drug solvability is achieved immediately in short time,usually within 30 - 60 minutes.

    3. The drug solution that can relieve irritation and obtainhigh serum level rapidly is an important considerationfor therapy such as serious infection,especially inantibiotic administration.

    95

  • 7/30/2019 Drug Administration 2011

    96/98

    96

  • 7/30/2019 Drug Administration 2011

    97/98

    THE EQUIPMENTS FOR THIS METHOD CONSIST OF INFUSION

    BOTTLES, INCLUDING A MAIN BOTTLE AND A MINI BOTTLE

    PEGGY BACK OF 250 ML, AND INFUSION SET. THE MINI

    PEGGY BACKBOTTLE USUALLY CONTAINS ANTIBIOTICS,

    WHILST MAIN BOTTLE IS SIMILAR TO THE CLASSICAL

    INFUSION SET WITH A RUBBER Y - SHAPE CHANNEL

    APPARATUS BELOW THE CLAMP OF THE MAIN BOTTLE.

    THE SECOND BOTTLE IS ALSO PROVIDED WITH THE

    REGULATORY CLAMP, WHILE THE OTHER HAS NOT CLAMP

    BUT A TAP IN THE Y-SHAPE CHANNEL APPARATUS TO

    REGULATE THE FLOW BY OPENING AND SHUTTING

    AUTOMATICALLY DEPENDING ON LIQUID PRESSURE. THIS

    BOTTLE IS HANGED OVER THE MAIN BOTTLE.

    97

    TO RESERVE AIR AND CONTROL THE NUMBER OF DRIPPING, THE BOTTLES

    ARE CONNECTED TO THE DRIP CHAMBER WITH A CLAMP, FURTHER THE

  • 7/30/2019 Drug Administration 2011

    98/98

    CHAMBER CONNECTED TO THE TIP OF NEEDLE THROUGH 1.5 - 3 M OF

    TUBE LINE. BELOW THE DRIP CHAMBER, A CLAMP REGULATES THE

    EXPECTED DROPS. THE PROCEDURES OF PREPARATION AND

    ADMINISTRATION OF INTRAVENOUS LIQUID

    1. Prick the spike into the rubber bottle cap of the infusion set.

    2. Hang the infusion bottles on a stand by the patient's bed, theneject the air in the tube line by flowing the first liquid drop out,regulated by the clamp.

    3. Shoot the needle into vein (aseptically, see the previousmentionedintravenous injection procedure), conducted by physician or nurse

    4. Loosen the clamp gently to flow the liquid till the expected number ofdrops by observing the drip in the drip chamber. Generally, thismedication lasts within 4 - 8 hours with the volume of 125 ml/hour.

    5. The concomitant drugs given along with this infusion are : Dopamin,Lidocaine, Insulin,and Heparin. In the administration of potentdrugs, the speed of dripping depends on the patient's clinical condition.The drip volume depends on the manufacturer's recommendation,ranged: 10, 15, 20, 50, and 60 drops/ml.

    In another setting, sterilized solid drug is administered through rubber hole in VC set